Peptide R

A triple agonist (GLP-1/GIP/glucagon) investigated for multi-receptor metabolic pathway research.

Supplied as a research-use-only preparation from a cGMP-compliant, ISO-certified facility and guaranteed to a minimum of 99% purity. Each lot is submitted for independent third-party analysis, and the certificate of analysis is tied to the lot code printed on the vial you receive.

Not for human or animal consumption. This compound is intended strictly for in-vitro laboratory and scientific research use. It is not approved by the FDA and is not for medical, diagnostic, or therapeutic use.

Form

Lyophilized powder

Lyophilized storage

Keep dry and sealed. Store per the vial label; protect from light.

Solvent

Bacteriostatic water (0.9% benzyl alcohol)

Reconstituted storage

Refrigerate after reconstitution. Do not shake — swirl to dissolve.

Handling

Allow the vial to reach room temperature before opening to limit condensation.

Category

GLP / Amylin Analogs

Class

Triple agonist (GLP-1/GIP/glucagon)

SKU

RETA-10

Purity

≥99% guaranteed

Origin

Manufactured in the USA

Availability

In stock

A single-molecule agonist at three receptors: GLP-1, GIP, and glucagon. Listed under a research designation; the specification tab carries the formula, molecular weight, and SKU that identify the material exactly.

Literature on triple incretin-receptor agonism examines multi-receptor signalling and energy expenditure in metabolic models.

On the evidence base. This receptor class is investigational. No compound in it is approved by the FDA or any comparable regulator.